31
Participants
Start Date
March 4, 2019
Primary Completion Date
October 3, 2020
Study Completion Date
October 3, 2020
Tranexamic Acid
Active drug is provided to participants as described based on the TXA arm they are randomized to.
Placebo
Normal saline is provided to participants if randomized to this treatment arm.
Children's Hospital of Philadelphia, Philadelphia
Nationwide Children's Hospital, Columbus
Primary Children's Hospital, Salt Lake City
University of California, Davis, Sacramento
Pediatric Emergency Care Applied Research Network
NETWORK
Daniel Nishijima, MD, MAS
OTHER